Anavatos Bio Inc. — Form D/A

Anavatos Bio Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2026-07-20. $393K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-07-20
• Form: D/A
• Accession: 0002067551-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Amount sold: $393K
• Minimum investment: $3K
• Investors: 4
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-545657

Issuer

• Name: Anavatos Bio Inc.
• CIK: 0002067551
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2025
• Address: 2314 NORTH 46TH STREET, SEATTLE, WA, 98103
• Phone: 206 437 3169

Officers, directors & promoters (2)

Other filings by this issuer (1)

More

• CIK 2067551 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search